Synonyms: (1R,4S)-trans-norsertraline | SEP-225,289 | SEP-225289
Compound class:
Synthetic organic
Comment: Dasotraline is a triple reuptake inhibitor [1,3]. Such compounds are also known as serotonin-norepinephrine-dopamine reuptake inhibitors, or SNDRIs. Structurally, dasotraline is a stereoisomer of an active metabolite of sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant.
|
|
No information available. |
Summary of Clinical Use |
Dasotraline is being assessed in Phase 3 clinical trial as a potential treatment for adults and children with attention-deficit-hyperactivity disorder (ADHD). Click here to link to ClinicalTrials.gov's list of Phase 3 dasotraline trials. |
Mechanism Of Action and Pharmacodynamic Effects |
Dasotraline inhibits monoamine reuptake via the serotonin, dopamine and norepinephrine transporters [3]. |